2018
DOI: 10.1016/j.lfs.2017.11.013
|View full text |Cite
|
Sign up to set email alerts
|

Thyroid hormone improves insulin signaling and reduces the activation of neurodegenerative pathway in the hippocampus of diabetic adult male rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 43 publications
0
8
0
Order By: Relevance
“…There is literature which reports alteration in insulin level for reducing cognitive impairment. Triiodothyronine treatment reduced neurodegeneration by restoring insulin signaling in diabetic rats (Prieto-Almeida et al, 2018).…”
Section: Insulinmentioning
confidence: 96%
See 1 more Smart Citation
“…There is literature which reports alteration in insulin level for reducing cognitive impairment. Triiodothyronine treatment reduced neurodegeneration by restoring insulin signaling in diabetic rats (Prieto-Almeida et al, 2018).…”
Section: Insulinmentioning
confidence: 96%
“…There is literature which reports alteration in insulin level for reducing cognitive impairment. Triiodothyronine treatment reduced neurodegeneration by restoring insulin signaling in diabetic rats (Prieto‐Almeida et al, ). Intranasal insulin treatment in rats activated insulin signaling which reduced cognitive dysfunction induced by methamphetamine (Beirami, Oryan, Seyedhosseini Tamijani, Ahmadiani, & Dargahi, ).…”
Section: Factors Involved In Regulationmentioning
confidence: 99%
“…T 3 negatively regulates the amyloid-β precursor protein (APP) gene (Belandia et al, 1998;Belakavadi et al, 2011), and rendering rats hyperthyroid by giving oral T 3 for 5 days strongly suppressed overall brain APP expression (Belakavadi et al, 2011). However, the sole study that tested this trait in a rat model for AD by giving supraphysiological doses of T 3 for 4 weeks showed no significant changes in brain amyloid β content by western blotting (Prieto-Almeida et al, 2018) (Figure 2). T 3 did reduce Tau hyper-phosphorylation and glycogen synthase kinase 3 α/β (GSK-3β) expression (Prieto-Almeida et al, 2018).…”
Section: Thyroid Hormone As a Repair Cue In Alzheimer's Diseasementioning
confidence: 99%
“…However, the sole study that tested this trait in a rat model for AD by giving supraphysiological doses of T 3 for 4 weeks showed no significant changes in brain amyloid β content by western blotting (Prieto-Almeida et al, 2018) (Figure 2). T 3 did reduce Tau hyper-phosphorylation and glycogen synthase kinase 3 α/β (GSK-3β) expression (Prieto-Almeida et al, 2018). Hyperactivity of each of these factors underlies AD pathogenesis and associates with amyloid β deposition, plaque forming and memory impairment (Hooper et al, 2008).…”
Section: Thyroid Hormone As a Repair Cue In Alzheimer's Diseasementioning
confidence: 99%
“…Although both hyperthyroidism and hypothyroidism have been related to disturbances in insulin signaling and glucose metabolism (Teixeira et al 2012), exogenous thyroid hormone administration in IR and glucose intolerance conditions have recently attracted considerable attention with favorable outcomes. Accumulating recent reports have shown that exogenous triiodothyronine (T 3 ) administration can decrease glycemia and improve insulin signaling in diabetic (Prieto-Almeida et al 2018) and obese rats (Panveloski-Costa et al 2018). It has been also demonstrated that T 3 is able to enhance insulin-stimulated glucose transport and glycolysis in skeletal muscles (Moreno et al 2011).…”
Section: Introductionmentioning
confidence: 99%